Papp L Roy & Associates Pfizer Inc Transaction History

Papp L Roy & Associates

$822 Million
Q2 2024

A detailed history of Papp L Roy & Associates transactions in Pfizer Inc stock. As of the latest transaction made, Papp L Roy & Associates holds 18,012 shares of PFE stock, worth $534,235. This represents 0.06% of its overall portfolio holdings.

Number of Shares

18,012

Previous 16,577 8.66%

Holding current value

$534,235

Previous $460,000 9.35%

% of portfolio

0.06%

Previous 0.06%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	BUY	$25.26 - $29.6 $36,248 - $42,476	1,435 Added 8.66%	18,012 $503,000
Q4 2023 Jan 19, 2024	SELL	$26.13 - $33.94 $11,758 - $15,272	-450 Reduced 2.64%	16,577 $477,000
Q3 2023 Oct 18, 2023	SELL	$32.09 - $37.51 $106,795 - $124,833	-3,328 Reduced 16.35%	17,027 $564,000
Q2 2023 Jul 17, 2023	SELL	$36.12 - $41.79 $173,376 - $200,592	-4,800 Reduced 19.08%	20,355 $746,000
Q4 2022 Jan 17, 2023	SELL	$41.75 - $54.5 $11,063 - $14,442	-265 Reduced 1.04%	25,155 $0
Q3 2022 Oct 21, 2022	BUY	$43.76 - $53.42 $12,034 - $14,690	275 Added 1.09%	25,420 $1.11 Million
Q2 2022 Aug 02, 2022	BUY	$46.53 - $55.17 $9,817 - $11,640	211 Added 0.85%	25,145 $1.32 Million
Q1 2022 May 06, 2022	SELL	$45.75 - $56.69 $7,731 - $9,580	-169 Reduced 0.67%	24,934 $1.29 Million
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $2,272 - $3,368	-55 Reduced 0.22%	25,103 $1.48 Million
Q2 2021 Aug 09, 2021	BUY	$35.91 - $40.68 $39,500 - $44,748	1,100 Added 4.57%	25,158 $985,000
Q1 2021 May 06, 2021	BUY	$33.49 - $37.77 $44,139 - $49,780	1,318 Added 5.8%	24,058 $872,000
Q4 2020 Feb 10, 2021	BUY	$33.47 - $42.56 $38,992 - $49,582	1,165 Added 5.4%	22,740 $837,000
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $71,882 - $84,334	-2,264 Reduced 9.5%	21,575 $792,000
Q1 2020 May 05, 2020	SELL	$27.03 - $38.62 $27,651 - $39,508	-1,023 Reduced 4.11%	23,839 $778,000
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $6,847 - $7,770	-208 Reduced 0.83%	24,862 $974,000
Q3 2019 Nov 04, 2019	BUY	$32.49 - $42.13 $25,992 - $33,704	800 Added 3.3%	25,070 $901,000
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $104,727 - $117,584	2,832 Added 13.21%	24,270 $1.05 Million
Q1 2019 May 09, 2019	BUY	$37.5 - $41.2 $12,412 - $13,637	331 Added 1.57%	21,438 $910,000
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $4,885 - $5,570	-127 Reduced 0.6%	21,107 $921,000
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $52,222 - $63,342	-1,515 Reduced 6.66%	21,234 $936,000
Q2 2018 Aug 09, 2018	SELL	$32.98 - $35.16 $19,787 - $21,095	-600 Reduced 2.57%	22,749 $825,000
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $44,993 - $52,198	1,410 Added 6.43%	23,349 $829,000
Q3 2017 Nov 06, 2017	BUY	$31.0 - $34.15 $680,109 - $749,216	21,939	21,939 $783,000

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Papp L Roy & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Papp L Roy & Associates with notifications on news.

Account

Papp L Roy & Associates Pfizer Inc Transaction History